The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes
Abstract
Substrate specificities, as reflected in kc/Km, were determined for the peptidyl prolyl cis-trans isomerase activities of cyclophilin and the FK-506 binding protein (FKBP). The substrates investigated were peptides of the general structure Suc-Ala-Xaa-Pro-Phe-p-nitroanilide, where Xaa = Gly, Ala, Val, Leu, Phe, His, Lys, on Glu. While kc/Km for cyclophilin-catalyzed isomerization shows little dependence on Xaa, kc/Km values for FKBP-catalyzed isomerization display a marked dependence on Xaa and vary over 3 orders of magnitude. An important outcome of this work is the discovery that Suc-Ala-Leu-Pro-Phe-pNA is a reactive substrate for FKBP (kc/Km = 640,000 M-1 s-1). This substrate can be used with FKBP concentrations that are low enough to allow, for the first time, accurate determinations of Ki values for tight-binding inhibitors of FKBP. Using this new assay, we found that FK-506 inhibits FKBP with Ki = 1.7 +/- 0.6 nM. The results of this work support the hypothesis that cyclophilin and FKBP are members of a family of peptidyl prolyl cis-trans isomerases and that the members of this family possess distinct substrate specificities that allow them to play diverse physiologic roles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On the size of the active site in proteases. I. Papain
Schechter, I., & Berger, A. (1967) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(67)80055-x · Cited by 5,204
Cyclophilin: A Specific Cytosolic Binding Protein for Cyclosporin A
Handschumacher, R. E., Harding, M. W., Rice, J., Drugge, R. J., & Speicher, D. W. (1984) · Science · doi:10.1126/science.6238408 · Cited by 1,673
Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins
Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T., & Schmid, F. X. (1989) · Nature · doi:10.1038/337476a0 · Cited by 1,407
A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase
Harding, M. W., Galat, A., Uehling, D. E., & Schreiber, S. L. (1989) · Nature · doi:10.1038/341758a0 · Cited by 1,396
Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin
Takahashi, N., Hayano, T., & Suzuki, M. (1989) · Nature · doi:10.1038/337473a0 · Cited by 1,078
Siekierka, J. J., Hung, S. H. Y., Poe, M., Lin, C. S., & Sigal, N. H. (1989) · Nature · doi:10.1038/341755a0 · Cited by 1,010
[17] The kinetics of reversible tight-binding inhibition
Williams, J. W., & Morrison, J. F. (1979) · Methods in Enzymology · doi:10.1016/0076-6879(79)63019-7 · Cited by 693
Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
Sawada, S., Suzuki, G., Kawase, Y., & Takaku, F. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.6.1797 · Cited by 413
Isolation and amino acid sequence of cyclophilin.
Harding, M. W., Handschumacher, R. E., & Speicher, D. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83945-5 · Cited by 293
Kester, W. R., & Matthews, B. W. (1977) · Biochemistry · doi:10.1021/bi00630a030 · Cited by 238
Cited by
Gething, M.-J., & Sambrook, J. (1992) · Nature · doi:10.1038/355033a0 · Cited by 4,123
The mechanism of action of cyclosporin A and FK506
Schreiber, S. L., & Crabtree, G. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90111-j · Cited by 2,127
Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands
Schreiber, S. L. (1991) · Science · doi:10.1126/science.1702904 · Cited by 1,494
Crystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid
Gamble, T. R., Vajdos, F. F., Yoo, S., Worthylake, D. K., Houseweart, M., Sundquist, W. I., & Hill, C. P. (1996) · Cell · doi:10.1016/s0092-8674(00)81823-1 · Cited by 706
“Phe-pNA appears to be a normal CypA substrate as judged by the kcat/Km ratio (Harrison and Stein, 1990b).”
BackgroundInfluentialRanganathan, R., Lu, K. P., Hunter, T., & Noel, J. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80273-1 · Cited by 699
Bierer, B. E., Mattila, P. S., Standaert, R. F., Herzenberg, L. A., Burakoff, S. J., Crabtree, G., & Schreiber, S. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9231 · Cited by 696
IMMUNOPHARMACOLOGY OF RAPAMYCIN
Abraham, R. T., & Wiederrecht, G. J. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.483 · Cited by 653
Proline-Dependent Structural and Biological Properties of Peptides and Proteins
Yaron, A., Naider, F., & Scharpe, S. (1993) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239309082572 · Cited by 551
Kofron, J. L., Kuzmic, P., Kishore, V., Colon-Bonilla, E., & Rich, D. H. (1991) · Biochemistry · doi:10.1021/bi00239a007 · Cited by 507
Nicolli, A., Basso, E., Petronilli, V., Wenger, R. M., & Bernardi, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.2185 · Cited by 479
Crystal Structure of the Cytoplasmic Domain of the Type I TGF β Receptor in Complex with FKBP12
Huse, M., Chen, Y.-G., Massagué, J., & Kuriyan, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80555-3 · Cited by 445
Mechanism of TGFβ receptor inhibition by FKBP12
Chen, Y.-G., Liu, F., & Massagué, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3866 · Cited by 363
Peters, D. H., Fitton, A., Plosker, G. L., & Faulds, D. (1993) · Drugs · doi:10.2165/00003495-199346040-00009 · Cited by 356
Side-chain effects on peptidyl-prolyl cis/trans isomerisation
Reimer, U., Scherer, G., Drewello, M., Kruber, S., Schutkowski, M., & Fischer, G. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1770 · Cited by 354
The Mechanism of Action of FK‐506 and Cyclosporin A
WIEDERRECHT, G., LAM, E., HUNG, S., MARTIN, M., & SIGAL, N. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb17137.x · Cited by 350
Peptidylproline cis‐trans‐isomerases: immunophilins
GALAT, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18189.x · Cited by 343
Peptidyl‐Prolyl cis/trans Isomerases and Their Effectors
Fischer, G. (1994) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199414151 · Cited by 308
Davis, T. L., Walker, J. R., Campagna-Slater, V., Finerty, P. J., Paramanathan, R., Bernstein, G., MacKenzie, F., Tempel, W., Ouyang, H., Lee, W. H., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000439 · Cited by 298
Heitman, J., Movva, N. R., Hiestand, P. C., & Hall, M. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1948 · Cited by 294
Protein quality control in the ER: The recognition of misfolded proteins
Määttänen, P., Gehring, K., Bergeron, J. J. M., & Thomas, D. Y. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2010.03.006 · Cited by 284
A ribosome-associated peptidyl-prolyl cis/trans isomerase identified as the trigger factor.
Stoller, G., Rücknagel, K. P., Nierhaus, K. H., Schmid, F. X., Fischer, G., & Rahfeld, J. U. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00177.x · Cited by 278
Prolyl Isomerases: Role in Protein Folding
Schmid, F. X., Mayr, L. M., Mucke, M., & Schonbrunner, E. R. (1993) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60563-x · Cited by 267
Molecular recognition in the HIV-1 capsid/cyclophilin A complex 1 1Edited by J. A. Wells
Yoo, S., Myszka, D. G., Yeh, C.-Y., McMurray, M., Hill, C. P., & Sundquist, W. I. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1051 · Cited by 264
Stamnes, M. A., Shieh, B.-H., Chuman, L., Harris, G. L., & Zuker, C. S. (1991) · Cell · doi:10.1016/0092-8674(91)90156-s · Cited by 263
Sinars, C. R., Cheung-Flynn, J., Rimerman, R. A., Scammell, J. G., Smith, D. F., & Clardy, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0231020100 · Cited by 254
Dumont, F. J., Staruch, M. J., Koprak, S. L., Siekierka, J. J., Lin, C. S., Harrison, R., Sewell, T., Kindt, V. M., Beattie, T. R., & Wyvratt, M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.3.751 · Cited by 250
Self-citationPirkl, F., & Buchner, J. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4595 · Cited by 179
Wiederrecht, G., Hung, S., Chan, H. K., Marcy, A., Martin, M., Calaycay, J., Boulton, D., Sigal, N., Kincaid, R. L., & Siekierka, J. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36676-1 · Cited by 115
Targeting FKBP isoforms with small-molecule ligands
Blackburn, E. A., & Walkinshaw, M. D. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.04.007 · Cited by 73
Yeh, W. C., Li, T. K., Bierer, B. E., & McKnight, S. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11081 · Cited by 61
Wu, X., Wang, L., Han, Y., Regan, N., Li, P.-K., Villalona, M. A., Hu, X., Briesewitz, R., & Pei, D. (2011) · ACS Combinatorial Science · doi:10.1021/co200057n · Cited by 36
Brath, U., & Akke, M. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.01.047 · Cited by 36
FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells
Maeda, K., Habara, M., Kawaguchi, M., Matsumoto, H., Hanaki, S., Masaki, T., Sato, Y., Matsuyama, H., Kunieda, K., Nakagawa, H., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13030 · Cited by 32
Samsudin, F., Gan, S. K.-E., & Bond, P. J. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.12.022 · Cited by 16
Metadata
- Authors
- Harrison, R. K., & Stein, R. L.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1990-04-24
- Volume
- 29
- Issue
- 16
- Pages
- 3813-3816
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2056959896
- Cited by
- 299
- References
- 16
- FWCI
- 9.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.